Simpson Thacher Represents Lead Arrangers in Financing of Thermo Fisher’s $11.5 Billion Acquisition of Qiagen
The Firm is representing JPMorgan Chase Bank, N.A. and Morgan Stanley Senior Funding, Inc., as lead arrangers, in connection with a bridge financing to Thermo Fisher Scientific Inc. in its announced tender offer for the acquisition of Qiagen N.V. for approximately $11.5 billion (including the assumption of debt). The proceeds of the bridge facility will be available to finance the tender offer to acquire the ordinary shares of Qiagen trading in Frankfurt and New York and to pay fees and expenses related thereto.
Thermo Fisher, the world leader in serving science, has more than 75,000 employees and serves customers within pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as in environmental, industrial quality and process control industries. Qiagen is a Dutch company headquartered in Germany and leading global provider of molecular diagnostics and sample preparation technologies.
The Simpson Thacher team includes Patrick Ryan, Christine Marshall and Libby Pica (Banking and Credit); Mark Brod, Ashley Yoon and Xochitl Romo (Capital Markets); and Morgan Otway (Tax).